Zobrazeno 1 - 10
of 131
pro vyhledávání: '"F. Dellatolas"'
Autor:
Vo, Josh N.1,2 (AUTHOR), Franson, Andrea3 (AUTHOR), Waszak, Sebastian M.4,5 (AUTHOR), Wu, Yi-Mi1,2 (AUTHOR), Becker, Nicole2 (AUTHOR), Chinnaiyan, Arul M.1,2 (AUTHOR), Robinson, Dan R.1,2 (AUTHOR) danrobi@med.umich.edu
Publikováno v:
Acta Neuropathologica Communications. 12/20/2024, Vol. 12 Issue 1, p1-10. 10p.
Autor:
Gotorbe, Célia1 (AUTHOR) cgotorbe@centrescientifique.mc, Segui, Fabien1 (AUTHOR) fsegui@centrescientifique.mc, Echavidre, William1 (AUTHOR) wechavidre@centrescientifique.mc, Durivault, Jérôme1 (AUTHOR) jdurivault@centrescientifique.mc, Blanchard, Thays1 (AUTHOR) thaysblanchard98@gmail.com, Vial, Valérie1 (AUTHOR) vial@centrescientifique.mc, Pagnuzzi-Boncompagni, Marina1 (AUTHOR) mpagnuzzi@centrescientifique.mc, Villeneuve, Rémy2 (AUTHOR) remy.villeneuve@chpg.mc, Amblard, Régis2 (AUTHOR) regis.amblard@chpg.mc, Garnier, Nicolas2 (AUTHOR) nicolas.garnier@chpg.mc, Ortholan, Cécile3 (AUTHOR) cecile.ortholan@chpg.mc, Serrano, Benjamin2 (AUTHOR) benjamin.serrano@chpg.mc, Picco, Vincent1 (AUTHOR) vpicco@centrescientifique.mc, Pouysségur, Jacques1,4 (AUTHOR) jacques.pouyssegur@univ-cotedazur.fr, Vucetic, Milica1 (AUTHOR) milica@centrescientifique.mc, Montemagno, Christopher1 (AUTHOR) milica@centrescientifique.mc
Publikováno v:
Current Oncology. Nov2024, Vol. 31 Issue 11, p7390-7402. 13p.
Publikováno v:
Alimentary Pharmacology & Therapeutics. 8:309-314
SUMMARY Background: Lansoprazole and omeprazole are proton pump inhibitors which both strongly inhibit acid secretion, resulting in a significant increase in serum gastrin levels. However, no direct comparison of recommended doses (20 mg for omeprazo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05ebc6dfa640cde40e39ae26feb6f61c
https://doi.org/10.1111/j.1365-2036.1994.tb00293.x
https://doi.org/10.1111/j.1365-2036.1994.tb00293.x
Publikováno v:
Pathologie Biologie. 53:503-510
Resume But de l'etude. – Evaluation de l'efficacite et de la tolerance de la pristinamycine (PRI), comparee a l'amoxicilline (AMX), toutes deux a la posologie de 3 g/jour pendant sept a dix jours dans la pneumonie aigue communautaire (PAC). Patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::008cb9a513d9514a22fa5ad01c7875bd
https://doi.org/10.1016/j.patbio.2005.07.010
https://doi.org/10.1016/j.patbio.2005.07.010
Publikováno v:
Pathologie-biologie. 53(8-9)
Evaluation of efficacy and safety of pristinamycin (PRI), compared with amoxicillin (AMX), both at 3 g daily for 7 to 10 days in adults with community-acquired pneumonia (CAP).Multinational, randomized, double blind, double dummy clinical trial of no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a26396cd80462488d0f27a0d973fea52
https://pubmed.ncbi.nlm.nih.gov/16181747
https://pubmed.ncbi.nlm.nih.gov/16181747
Autor:
P, Léophonte, C, Chidiac, H B, Drugeon, S, Strabach, S, Cabrillac-Rives, C, Chone, F, Dellatolas, C, Safran
Publikováno v:
Revue des maladies respiratoires. 21(2 Pt 1)
Pristinamycin is a bactericidal antibiotic whose spectrum covers the main respiratory pathogens including S. pneumoniae poorly sensitive to penicillin. It has not yet been evaluated in short course treatment of acute exacerbations of chronic obstruct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::df6fa5ccdcfc91170aec9e0fad355cfa
https://pubmed.ncbi.nlm.nih.gov/15211230
https://pubmed.ncbi.nlm.nih.gov/15211230
Publikováno v:
Alimentary pharmacologytherapeutics. 8(3)
Lansoprazole and omeprazole are proton pump inhibitors which both strongly inhibit acid secretion, resulting in a significant increase in serum gastrin levels. However, no direct comparison of recommended doses (20 mg for omeprazole and 30 mg for lan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9e88bb908a54227f6b2baa03867122e5
https://pubmed.ncbi.nlm.nih.gov/7918926
https://pubmed.ncbi.nlm.nih.gov/7918926
Plasma concentrations of lansoprazole and of its sulphone, sulphide and 5-hydroxylated metabolites were determined after oral administration of a single 30 mg dose and after 7 days of treatment with a daily 30 mg dose in 12 elderly subjects (mean age
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35979771ca8eff22100dbfa9c6539bf4
https://europepmc.org/articles/PMC1364622/
https://europepmc.org/articles/PMC1364622/
Publikováno v:
European journal of clinical pharmacology. 45(4)
The pharmacokinetics of lansoprazole (L) after a single oral dose of 30 mg was determined in 18 healthy volunteers, 17 renal failure patients and 24 hepatic failure patients; 8 hepatitis and 16 with compensated (CC) or uncompensated (UCC) cirrhosis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a1dbd7b77688dc0414ae3b6b173e854
https://pubmed.ncbi.nlm.nih.gov/8299672
https://pubmed.ncbi.nlm.nih.gov/8299672
Publikováno v:
European journal of clinical pharmacology. 43(2)
The effects of single doses and of 7 days of lansoprazole 10, 20 and 30 mg PO versus placebo on gastric acid secretion have been evaluated in 8 patients with high gastric acid secretion. The double blind crossover period was followed by a simple blin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9998451eeac7af40693cfe7d513e1c7
https://pubmed.ncbi.nlm.nih.gov/1425865
https://pubmed.ncbi.nlm.nih.gov/1425865